An Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of Afatinib, Alectinib, Ceritinib, Crizotinib, Dacomitinib, Erlotinib, Gefitinib, and Osimertinib in Human Serum
Mukai, Yuji, Wakamoto, Azusa, Hatsuyama, Tae, Yoshida, Tatsunari, Sato, Hideki, Fujita, Akihisa, Inotsume, Nobuo, Toda, Takaki
Published in Therapeutic drug monitoring (01.12.2021)
Published in Therapeutic drug monitoring (01.12.2021)
Get more information
Journal Article
Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer
Umehara, Kengo, Yama, Kaori, Goto, Keisuke, Wakamoto, Azusa, Hatsuyama, Tae, Honjo, Osamu, Saikai, Toyohiro, Fujita, Akihisa, Sato, Hideki
Published in Cancer control (01.01.2021)
Published in Cancer control (01.01.2021)
Get full text
Journal Article
Comparative Study of the Antiemetic Palonosetron for Lung Cancer Patients Treated with a Divided Dose of Cisplatin
Umehara, Kengo, Wakamoto, Azusa, Hatsuyama, Tae, Sato, Hideki, Kobayashi, Michiya, Fujita, Akihisa, Sekine, Kyuichiro
Published in Gan to kagaku ryoho (01.08.2016)
Get more information
Published in Gan to kagaku ryoho (01.08.2016)
Journal Article
Comparative study of an antiemetic NK1 receptor-antagonist in lung cancer patients treated with divided doses for Cisplatin
Sato, Hideki, Wada, Keiko, Umehara, Kengo, Otsu, Keisuke, Wakamoto, Azusa, Hatsuyama, Tae, Fujita, Akihisa, Sekine, Kyuichiro
Published in Gan to kagaku ryoho (01.06.2013)
Get more information
Published in Gan to kagaku ryoho (01.06.2013)
Journal Article
The Relationship Between Efficacy and Safety of Osimertinib Blood Concentration in Patients With EGFR Mutation-positive Lung Cancer: A Prospective Observational Study
HASHINO, YASUHISA, HATSUYAMA, TAE, IWAYAMA, KUNINORI, HOSHI, TAKANOBU, WAKAMOTO, AZUSA, OHTAKI, KOICHI, TODA, TAKAKI, SATO, HIDEKI
Published in In vivo (Athens) (01.11.2023)
Published in In vivo (Athens) (01.11.2023)
Get full text
Journal Article
Association of Nutritional Indices With Adverse Effects and Time-to-Treatment-Failure in Triple Therapy for Lung Cancer
Hashino, Yasuhisa, Matushita, Takumu, Hatsuyama, Tae, Wakamoto, Azusa, Goto, Keisuke, Hoshi, Takanobu, Iwayama, Kuninori, Ohtaki, Koichi, Toda, Takaki, Sato, Hideki
Published in In vivo (Athens) (01.03.2024)
Published in In vivo (Athens) (01.03.2024)
Get full text
Journal Article
Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in Lung Cancer
Shimizu, Atsuya, Fukasawa, Miyu, Mitani, Koharu, Goto, Keisuke, Wakamoto, Azusa, Hatsuyama, Tae, Hoshi, Takanobu, Hasegawa, Isao, Sato, Hideki
Published in In vivo (Athens) (01.01.2024)
Published in In vivo (Athens) (01.01.2024)
Get full text
Journal Article
Comparative study on safety after primary and secondary treatment in EGFR positive NSCLC administered Osimertinib
Umehara, Kengo, Gto, Keisuke, Okayama, Yuki, Noomote, Shiori, Toda, Takayuki, Okazaki, Yasuka, Wakamoto, Azusa, Hatsuyama, Tae, Honjo, Osamu, Sato, Hideki
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
P3-061Comparative study on safety after primary and secondary treatment in EGFR positive NSCLC administered Osimertinib
Umehara, Kengo, Gto, Keisuke, Okayama, Yuki, Noomote, Shiori, Toda, Takayuki, Okazaki, Yasuka, Wakamoto, Azusa, Hatsuyama, Tae, Honjo, Osamu, Sato, Hideki
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article